11-81890842-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000500502.5(MIR4300HG):n.941-8546T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0432 in 154,458 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.043 ( 155 hom., cov: 32)
Exomes 𝑓: 0.051 ( 3 hom. )
Consequence
MIR4300HG
ENST00000500502.5 intron
ENST00000500502.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.209
Publications
2 publications found
Genes affected
MIR4300HG (HGNC:52003): (MIR4300 host gene)
MIR4300 (HGNC:38184): (microRNA 4300) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.051 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MIR4300HG | ENST00000500502.5 | n.941-8546T>C | intron_variant | Intron 6 of 7 | 1 | |||||
| MIR4300HG | ENST00000530896.6 | n.473-8546T>C | intron_variant | Intron 3 of 4 | 3 | |||||
| MIR4300HG | ENST00000653173.1 | n.419-65911T>C | intron_variant | Intron 3 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0431 AC: 6535AN: 151724Hom.: 156 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6535
AN:
151724
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0508 AC: 324AN: 6382 AF XY: 0.0536 show subpopulations
GnomAD2 exomes
AF:
AC:
324
AN:
6382
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0509 AC: 133AN: 2614Hom.: 3 Cov.: 0 AF XY: 0.0498 AC XY: 67AN XY: 1346 show subpopulations
GnomAD4 exome
AF:
AC:
133
AN:
2614
Hom.:
Cov.:
0
AF XY:
AC XY:
67
AN XY:
1346
show subpopulations
African (AFR)
AF:
AC:
6
AN:
74
American (AMR)
AF:
AC:
1
AN:
8
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
4
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
5
AN:
94
European-Finnish (FIN)
AF:
AC:
10
AN:
426
Middle Eastern (MID)
AF:
AC:
99
AN:
1632
European-Non Finnish (NFE)
AF:
AC:
7
AN:
182
Other (OTH)
AF:
AC:
5
AN:
194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0431 AC: 6543AN: 151844Hom.: 155 Cov.: 32 AF XY: 0.0406 AC XY: 3016AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
6543
AN:
151844
Hom.:
Cov.:
32
AF XY:
AC XY:
3016
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
1924
AN:
41226
American (AMR)
AF:
AC:
579
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
203
AN:
3464
East Asian (EAS)
AF:
AC:
1
AN:
5182
South Asian (SAS)
AF:
AC:
83
AN:
4828
European-Finnish (FIN)
AF:
AC:
228
AN:
10596
Middle Eastern (MID)
AF:
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3269
AN:
67970
Other (OTH)
AF:
AC:
79
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
319
637
956
1274
1593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
53
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.